Stock Research for APHB

APHB

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

APHB Stock Chart & Research Data

The APHB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APHB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


APHB Due diligence Resources & Stock Charts

The APHB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APHB Detailed Price Forecast - CNN Money CNN View APHB Detailed Summary - Google Finance
Yahoo View APHB Detailed Summary - Yahoo! Finance Zacks View APHB Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View APHB Trends & Analysis - Trade-Ideas Barrons View APHB Major Holders - Barrons
NASDAQ View APHB Call Transcripts - NASDAQ Seeking View APHB Breaking News & Analysis - Seeking Alpha
Spotlight View APHB Annual Report - CompanySpotlight.com OTC Report View APHB OTC Short Report - OTCShortReport.com
TradeKing View APHB Fundamentals - TradeKing Charts View APHB SEC Filings - Bar Chart
WSJ View Historical Prices for APHB - The WSJ Morningstar View Performance/Total Return for APHB - Morningstar
MarketWatch View the Analyst Estimates for APHB - MarketWatch CNBC View the Earnings History for APHB - CNBC
StockMarketWatch View the APHB Earnings - StockMarketWatch MacroAxis View APHB Buy or Sell Recommendations - MacroAxis
Bullish View the APHB Bullish Patterns - American Bulls Short Pains View APHB Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View APHB Stock Mentions - StockTwits PennyStocks View APHB Stock Mentions - PennyStockTweets
Twitter View APHB Stock Mentions - Twitter Invest Hub View APHB Investment Forum News - Investor Hub
Yahoo View APHB Stock Mentions - Yahoo! Message Board Seeking Alpha View APHB Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for APHB - SECform4.com Insider Cow View Insider Transactions for APHB - Insider Cow
CNBC View APHB Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APHB - OTC Markets
Yahoo View Insider Transactions for APHB - Yahoo! Finance NASDAQ View Institutional Holdings for APHB - NASDAQ


Stock Charts

FinViz View APHB Stock Insight & Charts - FinViz.com StockCharts View APHB Investment Charts - StockCharts.com
BarChart View APHB Stock Overview & Charts - BarChart Trading View View APHB User Generated Charts - Trading View


Latest Financial News for APHB

AmpliPhi Biosciences Announces Presentation of Bacteriophage Therapy Case Study at ISHLT Annual Meeting
Posted on Tuesday April 03, 2018

AmpliPhi Biosciences Corporation , a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced the presentation of a case study of a lung transplant recipient suffering from a resistant Pseudomonas aeruginosa lung infection who received treatment with bacteriophage therapeutics, including AB-PA01.


APHB: Expecting to Meet with FDA in mid-2018 to Determine Regulatory Path Forward
Posted on Monday March 26, 2018

By David Bautz, PhD NYSE:APHB Business Update Positive Interim Results for Single-Patient Expanded Access Program On January 3, 2018, AmpliPhi Biosciences Corp. (NYSE:APHB) announced positive interim results ...


AmpliPhi Biosciences Announces Closing of Registered Direct Offering of Common Stock
Posted on Thursday March 22, 2018

AmpliPhi Biosciences Corporation , a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced the closing of its previously announced registered direct offering of 2,743,640 shares of its common stock at a price of $1.10 per share.


AmpliPhi Biosciences Announces Registered Direct Offering of Common Stock
Posted on Tuesday March 20, 2018

AmpliPhi Biosciences Corporation , a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced that it has entered into definitive purchase agreements with certain institutional investors to sell in a registered direct offering 2,743,640 shares of its common stock at a price of $1.10 per share, for gross proceeds of approximately ...


Enter a stock symbol to view the stock details.